A federal judge has denied the company’s request to block the release of records pertaining to the insurance company’s malpractice coverage, which it argued could be used to unfairly target women.
In a ruling last month, U.S. District Judge Paul A. Grieve granted a preliminary injunction against the company.
In response, the company issued a statement saying it plans to appeal the decision.
“The court’s ruling today is a win for women across the country who are victims of predatory, unlawful, and unsafe practices at Aptas, and it also affirms the rights of women who are harmed by Apta,” the statement read.
“This litigation has been going on for nearly a year, and Apts is still in the midst of defending itself against the claims.”
Aptas filed a lawsuit against the insurance companies and other entities last year alleging that the company violated the terms of its policies by not disclosing that it was covering a significant percentage of its employees with pre-existing conditions.
The insurer said it had more than 200 employees with chronic illnesses, which included diabetes, hypertension, and heart disease.
The company said the number of employees with such conditions had grown by nearly 20% over the past decade.
The company also said it made the decision to release the information to the public in the hopes that it would “provide greater transparency and transparency about Aptams malpractice policies, as well as encourage the public to better understand Aptamans policies.”
In the ruling, Grieve said Aptaus “was entitled to access to the records for the purposes of defending its claims,” but noted that Aptos claims “did not demonstrate that any of the records were intentionally withheld or intentionally altered.”
He noted that a large number of the company`s workers with chronic illness had been covered by Aaptas` insurance policies, which allowed the company to cover them for more than 90% of the time, and that the number was higher in other industries, such as medical care, where insurance policies are typically only available to people who qualify for insurance.
In addition, the judge found that Aapta did not show any evidence that it violated any laws or regulations that govern health care providers.
“Although the record shows that Aps had access to all of its claims data, it did not provide any proof that it had acted with any kind of malice, and therefore Aps could not establish that it intended to mislead the public or hurt its competitors,” Grieve wrote.
“Aps did not even try to show that its claims were false, and, thus, did not establish any kind, or even a strong, evidence of a malpractice violation.
Aptasi also did not offer any explanation for the delay in disclosing the information, nor did it provide any evidence of any harm to its business.”
The judge also noted that, as the case proceeds, it is likely to have a “material impact on Aps` ability to conduct business,” and that it is “highly unlikely that Aaps` financial condition would have recovered from the loss of the claims, and its prospects for recovery would have been even more uncertain.”
A spokesperson for Aptanas said in a statement to The Verge that the case is about protecting women and families from the risk of having their health and personal information shared by insurance companies without their consent.
“Today’s decision is the first step in protecting Aptans customers and patients from the harms of predatory insurance practices, and we are hopeful that our appeal will help ensure that the information will not be released to the general public,” the spokesperson said.
“We will continue to fight this case vigorously.”